G

Glaukos

Medical devices for glaucoma treatment

Senior Quality Engineer 2 / Senior Quality Specialist 2

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeSan Clemente, CA, USA$107.7k - $134.6kIn-person

About the Job

Requirements

  • A bachelor's degree in Engineering, Science, or a related field is required.
  • At least 8 years of relevant experience, including at least 5 years in pharmaceuticals, is required.
  • Experience with QC analytical method validation, raw material and final product testing, and stability programs in a regulated environment is required.
  • Strong knowledge of 21 CFR Part 820, ISO 13485, ISO 14971, 21 CFR Parts 210/211, USP, and ICH guidelines is required.

Responsibilities

  • Work with the Manufacturing and QC Analytical Departments as the Quality Assurance representative, providing oversight and support to ensure compliance with GMP.
  • Drive quality on the manufacturing floor, including nonconformance investigations and process optimization.
  • Identify compliance risks and ensure quality and regulatory compliance with 21 CFR Parts 210/211 and 820, ISO 13485, USP, and ICH guidelines.
  • Support product validation (IQ/OQ/PQ), CAPAs, and quality system improvements.
  • Collaborate with R&D, Operations, Clinical, and Regulatory teams to bring new products to market and improve existing products.
  • Guide audits and promote a culture of compliance and quality.
  • Author and perform quality reviews of deviations, out-of-specification result investigations, non-conformances, and CAPAs as needed, ensuring Quality System records are completed according to guidelines and on time.

Desired Qualifications

  • At least 10 years of relevant experience is preferred.
  • ASQ certifications such as CQE, CQA, or CBA are a plus.

About the Company

Glaukos

Medical devices for glaucoma treatment

Glaukos focuses on ophthalmology by developing and commercializing medical devices and therapies for glaucoma, corneal disorders, and retinal diseases. Its products mainly target surgeons who treat eye conditions, with a core technology in micro invasive glaucoma surgery (MIGS). The company’s MIGS devices, such as the Trabecular Micro Bypass Stent and next-generation iStent, are implanted in the eye to improve outflow of eye fluid and lower intraocular pressure, offering a less invasive option compared with traditional surgeries. Glaukos differentiates itself by pioneering MIGS and bringing the first US-approved MIGS device to market in 2012, continuing to expand its portfolio through research, development, and strategic acquisitions. The company aims to improve patient care by providing safer, effective, and longer-lasting treatment options for glaucoma and related eye diseases, addressing unmet needs in ophthalmology.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Aliso Viejo, CA
Founded
1998

Recently Posted Jobs

Explore more opportunities at Glaukos

See more jobs